NBT Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-20
Closed -$1.59K – 780
2026
Q2
$1.59K Hold
20
– – ﹤0.01% 912
2026
Q1
$1.5K Buy
+20
New +$1.58K ﹤0.01% 855
2025
Q2
– Sell
-17,050
Closed -$514K – 810
2025
Q1
$514K Hold
17,050
– – 0.04% 265
2024
Q4
$596K Hold
17,050
– – 0.04% 257
2024
Q3
$683K Hold
17,050
– – 0.05% 248
2024
Q2
$813K Hold
17,050
– – 0.06% 231
2024
Q1
$739K Hold
17,050
– – 0.05% 230
2023
Q4
$863K Hold
17,050
– – 0.07% 213
2023
Q3
$773K Buy
+17,050
New +$703K 0.07% 185

Other funds holding IONS

NBT Bank's IONS Position: Q3 2026 in Review

NBT Bank sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 20 shares — an estimated $1.59K sold.

NBT Bank first reported a position in IONS in Q3 2023 and held it in 9 quarters. The position peaked at $863K in Q4 2023. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • NBT Bank reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • NBT Bank sold 20 Ionis Pharmaceuticals shares in Q3 2026, an estimated $1.59K.
  • NBT Bank first reported a position in Ionis Pharmaceuticals in Q3 2023 and held it in 9 quarters.
  • NBT Bank's Ionis Pharmaceuticals position peaked at $863K in Q4 2023.
  • 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on NBT Bank's 13F filing for Q3 2026, filed 21 Oct 2026.